Skip to main content
. 2015 Mar 18;5(1):969–996. doi: 10.3390/life5010969

Table 1.

Average and maximal rF values for different solutes and vesicle preparation methods.

Solute MW (kDa) Lipids Method c ˂rF˃ ± SD (n) d rF,max Note
Calcein 0.67 POPC M1 n.a. n.a. e
Dextran-RITC 10 POPC M1 12 ± 3.8 (11) 19.8 f
BSA-FITC 66 POPC M1 5.7 ± 4.5 (69) 29 f
BSA-FITC 66 PB33PEO29 a M1 2.9 ± 0.2 (19) 3.2 g
BSA-FITC 66 POPC M2 3.7 ± 1.4 (48) 7.7 g
BSA-FITC 66 POPC ± oleate b M3 3.5 ± 1.1 (13) 8.6 f
APC 104 POPC M1 3.9 ± 1.6 (19) 7.3 h
Dextran-FITC 150 POPC M1 2.7 ± 1.0 (15) 5.1 f
Dextran-FITC 150 POPC ± oleate b M3 3.8 ± 1.1 (55) 6.4 f
PE 240 POPC M1 6.1 ± 2.3 (11) 9.9 i

a Copolymer vesicle made by Poly(butadiene-b-ethylene oxide), average MW 1.85 kDa; b POPC:oleate has been varied as 100:0, 80:20, 50:50 (without observing any statistical difference among the samples); c M1—hydration of thin lipid films deposited on glass beads; M2—hydration of freeze-dried lipid vesicles; M3—ethanol injection method. d ˂rF˃, SD, and n stand for, respectively, the mean value, the standard deviation, and the number of observations (number of vesicles). e No vesicles with fluorescence higher than the background were systematically observed; f [solute]bulk from 0.63 to 5 μM, intravesicle concentration not dependent from vesicle size and solute concentration; g [BSA-FITC]bulk = 4 μM, intravesicle concentration not dependent from vesicle size; h [APC]bulk from 0.5 to 5 μM, intravesicle concentration not dependent from vesicle size, yet dependent from solute concentration in inverse way; i [PE]bulk from 0.16 to 0.25 μM, intravesicle concentration not dependent from vesicle size and solute concentration; “n.a.” stands for “not available”.